# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our t...
Senseonics stock drops on reverse split announcement despite record U.S. patient growth and 91% jump in Q3 revenue.
Preliminary unaudited revenue of $8.1 million for Q3 2025Generated record quarterly new patient starts in Q3 2025Established re...
Senseonics continues to expect full-year 2025 global net revenue to be approximately $34-38 million as we continue to roll out ...
CGM commercial operations to transition from Ascensia Diabetes Care to SenseonicsBrian Hansen to be appointed Chief Commercial ...
Barclays analyst Matt Miksic initiates coverage on Senseonics Holdings (AMEX:SENS) with a Overweight rating and announces Pr...